Christof Von Eiff
Berlin, BE 10117, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Cost-effectiveness of RSVpreF for the prevention of respiratory syncytial virus illness among high-risk adults in Germany.
Journal: Expert review of vaccines
Published: July 31, 2026
Leveraging Large Language Models to Address Common Vaccination Myths and Misconceptions.
Journal: Vaccines
Published: June 02, 2026
Long-term sequelae after tick-borne encephalitis in Germany: a nationwide claims-based matched cohort study.
Journal: Ticks and tick-borne diseases
Published: April 08, 2026
Cost-Effectiveness of Alternative Immunization Strategies to Protect Infants Against Respiratory Syncytial Virus in Germany: A Decision Modeling Study.
Journal: Infectious diseases and therapy
Published: December 03, 2025
RSV Monitoring in Germany: A Critical Overview of Available Surveillance Systems.
Journal: Journal of clinical medicine
Published: August 05, 2025
Evaluating the impact of population-based and cohort-based models in cost-effectiveness analysis: a case study of pneumococcal conjugate vaccines in infants in Germany.
Journal: Journal of medical economics
Published: July 21, 2025
Cost-effectiveness of bivalent respiratory syncytial virus prefusion F vaccine for prevention of respiratory syncytial virus among older adults in Germany.
Journal: Expert review of vaccines
Published: December 18, 2024
Incidence of RSV-related hospitalizations for ARIs, including CAP: Data from the German prospective ThEpiCAP study.
Journal: The Journal of infection
Published: November 19, 2024
Estimated Incidence Rate of Specific Types of Cardiovascular and Respiratory Hospitalizations Attributable to Respiratory Syncytial Virus Among Adults in Germany Between 2015 and 2019.
Journal: Influenza and other respiratory viruses
Published: October 16, 2024
Impact of Revised Vaccination Recommendations for Mature Infants on Premature Infants' Vaccination Compliance in Germany.
Journal: Infectious diseases and therapy
Published: October 07, 2024
Economic burden of respiratory syncytial virus in adults in Germany - a health claims analysis between 2015 and 2018.
Journal: Journal of medical economics
Published: August 06, 2024
Last Updated: 09/26/2026